Cambridge Healthtech Institute
Rod Eymael is a seasoned business development professional currently serving as Sr. Business Development Manager at Cambridge Innovation Institute since September 2023. With a background in technology and service provider engagement, Rod has extensive experience in connecting stakeholders in the pharma and biotechnology sectors through various lead generation initiatives. Prior roles include Business Development Manager at Cambridge Healthtech Institute and Sales Manager at Keyword Connects, where Rod was instrumental in developing sales processes that led to a successful acquisition. Rod's earlier career includes sales management positions at DealerRater and First Advantage, and foundational roles in automotive sales. Rod holds a Bachelor's degree in Business from Candido Mendes University and has received multiple awards for sales leadership throughout the career.
Cambridge Healthtech Institute
1 followers
Cambridge Healthtech Institute – Your Life Science Network Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Barnett Educational Services, Cambridge Meeting Planners and Healthtech Publishing, which includes publications such as Bio-IT World, Clinical Informatics News, and Diagnostics World, as well as numerous e-newsletters. Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with a heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business. The executive team has a combined 170+ years of experience and drives the CHI portfolio to deliver cutting-edge information and the most up-to-date research.